PCN Insights, News, Videos, and More

When choosing an antipsychotic for acute treatment of psychosis, evaluating the drug's side effects is an important step, Dr. Stephen Marder said at a 26th Annual National Psychopharmacology Update session.

Psychedelic medicine biotech firm MindMed has announced it has begun a study for a “neutralizer” technology that could shorten and stop the effects of an LSD trip during therapy, paving the way for an “emergency shut-off switch” for...

Caregivers of patients with schizophrenia, an often overlooked target for education, feel they act as a mediator between the patient and their medical team and are responsible for the patient's therapeutic adherence, according to survey...

Education on schizophrenia management should focus on the benefits of newer therapies, strategies to ease the patient transition from oral treatments, and ways to decrease key barriers, survey respondents said.

Trauma or maltreatment during childhood is associated with changes in subregions of the amygdala and hippocampus in adults with major depressive disorder (MDD), according to a study published in the Journal of Psychiatry & Neuroscience.